文献速递衰弱、肌少症与跌倒

韩国社区老年人肌少症患病率:基于EWGSOP2定义

Prevalence of sarcopenia in community-dwelling older adults using the definition of the European Working Group on Sarcopenia in Older People 2: findings from the Korean Frailty and Aging Cohort Study.
PubMed 文献 · Age Ageing · 2019-01-01

该横断面研究纳入韩国衰弱与老龄队列研究(KFACS)中2099名70-84岁可走动社区老年人,采用EWGSOP2定义与算法评估肌少症患病率。结果显示患病率随所用肌力测量工具与低肌肉量ASM指标不同而变化,使用SARC-F筛查的临床算法时可能肌少症、确诊肌少症与严重肌少症患病率均较低。

要点

  • EWGSOP2定义下肌少症患病率因所用肌力工具与ASM指标不同而差异明显。
  • 低肌力合并低肌肉量者男性4.6-14.5%、女性6.7-14.4%。
  • 以SARC-F为筛查工具时可能肌少症2.2%、确诊1.4%、严重0.8%。

核心结论

  • 社区老年人肌少症患病率随EWGSOP2定义中所用肌力测量工具及低肌肉量ASM指标的不同而变化。
  • 采用以SARC-F为筛查工具的临床算法时,可能肌少症、确诊肌少症与严重肌少症患病率均较低。

研究设计与样本

  • 横断面研究,数据来自韩国衰弱与老龄队列研究(KFACS)。
  • 共纳入2099名70-84岁可走动社区老年人,平均年龄75.9±4.0岁,女性占49.8%。
  • 握力、步速、五次坐立试验、起立行走计时试验与简短体能测试评估躯体功能,双能X线吸收法测四肢骨骼肌量(ASM)。

主要发现

  • 低肌力合并低肌肉量者男性为4.6-14.5%、女性为6.7-14.4%。
  • 低肌力、低肌肉量合并低躯体功能者男性为0.3-2.2%、女性为0.2-6.2%。
  • 以SARC-F为筛查工具时可能肌少症患病率2.2%、确诊肌少症1.4%、严重肌少症0.8%。

关键数值与推荐

  • 肌少症判定采用EWGSOP2定义与算法。
  • 肌力与躯体功能评估工具包括握力、惯常步速、五次坐立试验、起立行走计时试验与简短体能测试。
  • 低肌肉量以双能X线吸收法测得的ASM指标判定,筛查工具为SARC-F。

临床怎么用

  • 在社区老年肌少症评估中应说明所用EWGSOP2组件与测量工具,以便解释患病率差异。
  • 可先用SARC-F筛查,再按EWGSOP2算法行肌力、肌肉量与躯体功能评估。
  • 判读患病率数据时需考虑肌力测量工具与ASM指标选择对结果的影响。

局限性

  • 原文摘要未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: in October 2018, the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) updated their original definition of sarcopenia to reflect the scientific and clinical evidence that has accumulated over the last decade. OBJECTIVE: to determine the prevalence of sarcopenia in a large group of community-dwelling older adults using the EWGSOP2 definition and algorithm. DESIGN: a cross-sectional study. SETTING: the nationwide Korean Frailty and Aging Cohort Study (KFACS). SUBJECTS: a total of 2,099 ambulatory community-dwelling older adults, aged 70-84 years (mean age, 75.9 ± 4.0 years; 49.8% women) who were enrolled in the KFACS. METHODS: physical function was assessed by handgrip strength, usual gait speed, the five-times-sit-to-stand test, the timed up-and-go test, and the Short Physical Performance Battery. Appendicular skeletal muscle mass (ASM) was measured by dual-energy X-ray absorptiometry. RESULTS: according to the criteria of the EWGSOP2, the sarcopenia indicators of combined low muscle strength and low muscle quantity were present in 4.6-14.5% of men and 6.7-14.4% of women. The severe sarcopenia indicators of combined low muscle strength, low muscle quantity and low physical performance were present in 0.3-2.2% of men and 0.2-6.2% of women. Using the clinical algorithm with SARC-F as a screening tool, the prevalence of probable sarcopenia (2.2%), confirmed sarcopenia (1.4%) and severe sarcopenia (0.8%) was low. CONCLUSIONS: the prevalence of sarcopenia among community-dwelling older individuals varied depending on which components of the revised EWGSOP2 definition were used, such as the tools used to measure muscle strength and the ASM indicators for low muscle mass.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Kim M, Won CW. Prevalence of sarcopenia in community-dwelling older adults using the definition of the European Working Group on Sarcopenia in Older People 2: findings from the Korean Frailty and Aging Cohort Study. Age Ageing. 2019. PMID: 31329815. doi:10.1093/ageing/afz091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。